Cutaneous plasmacytosis with perineural involvement.

Case Rep Dermatol Med

Department of Dermatology, Davis Health System, University of California, 3301 C Street, Suite 1400, Sacramento, CA 95816, USA.

Published: May 2014

Importance. Cutaneous and systemic plasmacytosis are rare conditions of unknown etiology with characteristic red-brown skin lesions and a mature polyclonal plasma cell infiltrate within the dermis. Perineural plasma cell infiltrates may be a histologic clue to the diagnosis of cutaneous plasmacytosis. Observations. Our patient had a five-year history of persistent reddish-brown plaques on the neck and trunk without systemic symptoms. Histologic examination showed dermal perivascular and perineural plasma cells with excess lambda light chain expression. Due to decreased quality of life caused by his skin lesions, he was placed on a chemotherapeutic regimen with bortezomib. Conclusions and Relevance. The patient was diagnosed with cutaneous plasmacytosis based on classic histopathology results with a recently characterized pattern of perineural involvement. Bortezomib therapy was initiated to manage his skin eruption, which has not been previously described as a treatment for this chronic condition.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006542PMC
http://dx.doi.org/10.1155/2014/840845DOI Listing

Publication Analysis

Top Keywords

cutaneous plasmacytosis
12
perineural involvement
8
skin lesions
8
plasma cell
8
perineural plasma
8
cutaneous
4
perineural
4
plasmacytosis perineural
4
involvement cutaneous
4
cutaneous systemic
4

Similar Publications

Cutaneous plasmacytosis (CP) is a rare condition characterized by benign proliferation of mature plasma cells in the skin. It presents as reddish-brown macules, papules, or plaques, typically located on the neck, face, and trunk. The etiology remains unknown, though it is believed to be reactive rather than malignant.

View Article and Find Full Text PDF
Article Synopsis
  • The study compared the safety profiles of four anti-herpesvirus drugs—acyclovir, ganciclovir, valaciclovir, and foscarnet—using data from the FDA Adverse Event Reporting System from 2004 to 2023.
  • All drugs showed significant risks for hematotoxicity, with ganciclovir and foscarnet being the most myelosuppressive.
  • Specific associations were noted: foscarnet posed the highest risk for renal impairment and seizures, while acyclovir had strong ties to neurotoxicity and severe skin reactions.
View Article and Find Full Text PDF
Article Synopsis
  • Rare skin diseases with plasma cell infiltration can transition from benign to malignant, featuring presentations like purplish or reddish-brown plaques and nodules.
  • A unique case of lichen planus showed typical histopathological features but involved unusual plasma cells with restricted light chain expression.
  • Patients should be monitored for changes in their rash, and clinicians may need to perform repeated biopsies and multisystem evaluations to track the disease's progression.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!